Figure 3
Kaplan–Meier analysis for OS based on VEGF-A, KDR, pKDR-Y1775 and MVD levels in sunitinib-treated metastatic RCC patients.
Figure 3 | British Journal of Cancer
Kaplan–Meier analysis for OS based on VEGF-A, KDR, pKDR-Y1775 and MVD levels in sunitinib-treated metastatic RCC patients.
